Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

  • Michael Donahoe,
  • Vincent G. Valentine,
  • Nydia Chien,
  • Kevin F. Gibson,
  • Jay S. Raval,
  • Melissa Saul,
  • Jianmin Xue,
  • Yingze Zhang,
  • Steven R. Duncan

Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

  • Michael Donahoe, 
  • Vincent G. Valentine, 
  • Nydia Chien, 
  • Kevin F. Gibson, 
  • Jay S. Raval, 
  • Melissa Saul, 
  • Jianmin Xue, 
  • Yingze Zhang, 
  • Steven R. Duncan
PLOS
x

In the penultimate sentence of the Results section of the Abstract, the plus sign should be a plus-or-minus sign. The correct sentence is: One-year survival of trial subjects was 46±15% vs. 0% among historical controls.

In Table 2, spaces are missing before the acronym “PEEP” in the “Pre-Rx O2” and “Post-Rx O2” columns. Please see the correct Table 2 here.

Reference

  1. 1. Donahoe M, Valentine VG, Chien N, Gibson KF, Raval JS, Saul M, et al. (2015) Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis. PLoS ONE 10(6): e0127771. pmid:26083430